Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations

Felix Carl Saalfeld, Carina Wenzel, Petros Christopoulos, Sabine Merkelbach‐Bruse, Timm M. Reißig, Silke Laßmann, Sebastian Thiel, Jan Stratmann, Ralf Marienfeld, Johannes Berger, Alexander Desuki, Janna-Lisa Velthaus, Diego Kauffmann‐Guerrero, Albrecht Stenzinger, Sebastian Michels, Thomas Herold, Michael Krämer, Sylvia Herold, Amanda Tufman, Sonja Loges, Jürgen Alt, Maria Joosten, Gerlinde Schmidtke-Schrezenmeier, Martin Sebastian, Susann Stephan-Falkenau, Cornelius F. Waller, Marcel Wiesweg, Jürgen Wolf, Michael Thomas, Daniela E. Aust, Martin Wermke